Total raised: $31M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.03.2025 | Seed | $31M | - |
Mentions in press and media 5
| Date | Title | Description |
| 07.03.2025 | TRIMTECH Therapeutics: A New Dawn in Neurodegenerative Disease Treatment | In the heart of Cambridge, a biotech revolution is brewing. TRIMTECH Therapeutics has emerged as a beacon of hope for those grappling with neurodegenerative diseases. With a recent funding boost of €28.6 million, the company is poised to ta... |
| 06.03.2025 | TRIMTECH Therapeutics raises €28.6 million for treatment of neurodegenerative diseases | Cambridge-based TRIMTECH Therapeutics, a BioTech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, announced the closing of its €28.6 million Seed funding round. The financing was led by ... |
| 06.03.2025 | TRIMTECH Therapeutics: $31 Million (Seed) Raised For Advancing Targeted Protein Degradation For Treating Neurodegenerative Diseases | TRIMTECH Therapeutics, a biotechnology company harnessing targeted protein degradation (TPD) for treating neurodegenerative diseases, announced the closing of its $31 million (£25 million) seed funding round. Cambridge Innovation Capital (C... |
| 05.03.2025 | Trimtech Therapeutics Raises $31M in Seed Funding | Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding. The round was led by Cambridge Innovation Capital (CIC)... |
| - | TRIMTECH Therapeutics | “Trimtech Therapeutics – Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates” |